Three atypical lethal cases associated with acute Zika virus infection in Suriname

IDCases

Volumn 5, Issue , 2016, Pages 49-53

  Zonneveld, Rens ^a,b   Roosblad, Jimmy ^a   Staveren, Jan Willem van ^a   Wilschut, Jan C ^b   Vreden, Stephen G S ^a   Codrington, John ^a  

^a ACADEMIC HOSPITAL PARAMARIBO   (Suriname)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Hemorrhagic fever; Sepsis; Zika; ZIKV

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; AMOXICILLIN PLUS CLAVULANIC ACID; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; CREATINE KINASE; GENTAMICIN; LACTATE DEHYDROGENASE;

ADULT; ARTHRITIS; ARTICLE; BLOOD CLOTTING DISORDER; CARDIOPULMONARY INSUFFICIENCY; CASE REPORT; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; DISEASE SEVERITY; FEVER; HUMAN; HYPOXIA; INFLAMMATION; MALE; MIDDLE AGED; MIXED INFECTION; PARTIAL THROMBOPLASTIN TIME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RASH; REAL TIME POLYMERASE CHAIN REACTION; SEPTIC SHOCK; SURINAME; TACHYPNEA; THROMBOCYTE COUNT; UREA NITROGEN BLOOD LEVEL; VERNER MORRISON SYNDROME; VIRUS INFECTION; VOMITING; ZIKA VIRUS INFECTION;

EID: 84979649666     PISSN: 22142509     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idcr.2016.07.009     Document Type: Article

References (25)

1. [1] Petersen, L.R., Jamieson, D.J., Powers, A.M., Honein, M.A., Zika Virus. N Engl J Med 374:16 (2016), 1552–1563.
2. [2] Fauci, A.S., Morens, D.M., Zika virus in the americas − yet another arbovirus threat. N Engl J Med 374:7 (2016), 601–604.
3. [3] Enfissi, A., Codrington, J., Roosblad, J., Kazanji, M., Rousset, D., Zika virus genome from the Americas. Lancet 387:10015 (2016), 227–228.
4. [4] Brasil, P., Pereira, J.P. Jr., Raja Gabaglia, C., Damasceno, L., Wakimoto, M., Ribeiro Nogueira, R.M., et al. Zika virus infection in pregnant women in rio de janeiro − preliminary report. N Engl J Med(March), 2016.
5. [5] Cao-Lormeau, V.M., Blake, A., Mons, S., Lastère, S., Roche, C., Vanhomwegen, J., et al. Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 387:10027 (2016), 1531–1539.
6. [6] Sarmiento-Ospina, A., Vásquez-Serna, H., Jimenez-Canizales, C.E., Villamil-Gómez, W.E., Rodriguez-Morales, A.J., Zika virus associated deaths in Colombia. Lancet, 16(April), 2016.
7. [7] Karimi, O., Goorhuis, A., Schinkel, J., Codrington, J., Vreden, S.G., Vermaat, J.S., et al. Thrombocytopenia and subcutaneous bleedings in a patient with Zika virus infection. Lancet 387:10022 (2016), 939–940.
8. [8] Arzuza-Ortega, L., Polo, A., Pérez-Tatis, G., López-García, H., Parra, E., Pardo-Herrera, L.C., et al. Fatal sickle cell disease and Zika virus infection in girl from Colombia. Emerg Infect Dis 22:5 (2016), 925–927.
9. [9] Pastorino, B., Bessaud, M., Grandadam, M., Murri, S., Tolou, H.J., Peyrefitte, C.N., Development of a TaqMan RT-PCR assay without RNA extraction step for the detection and quantification of African Chikungunya viruses. J Virol Methods 124:1–2 (2005), 65–71.
10. [10] Lanciotti, R.S., Calisher, C.H., Gubler, D.J., Chang, G.J., Vorndam, A.V., Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 30:3 (1992), 545–551.
11. [11] Lanciotti, R.S., Kosoy, O.L., Laven, J.J., Velez, J.O., Lambert, A.J., Johnson, A.J., et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State Micronesia, 2007. Emerg Infect Dis 14:8 (2008), 1232–1239.
12. [12] Chen, H., Parimelalagan, M., Lai, Y.L., Lee, K.S., Koay, E.S., Hapuarachchi, H.C., et al. Development and evaluation of a SYBR green-based real-time multiplex RT-PCR assay for simultaneous detection and serotyping of dengue and chikungunya viruses. J Mol Diagn 17:6 (2015), 722–728.
13. [13] Torres, J.R., Leopoldo Códova, G., Castro, J.S., Rodríguez, L., Saravia, V., Arvelaez, J., et al. Chikungunya fever: atypical and lethal cases in the Western hemisphere. A Venezuelan experience. IDCases 2:1 (2015), 6–10.
14. [14] Crosby, L., Perreau, C., Madeux, B., Cossic, J., Armand, C., Herrmann-Storke, C., et al. Severe manifestations of chikungunya virus in critically ill patients during the 2013–2014 Caribbean outbreak. Int J Infect Dis 48 (2016), 78–80.
15. [15] Miranda, C.H., Borges, Mde C., Schmidt, A., Pazin-Filho, A., Rossi, M.A., Ramos, S.G., et al. A case presentation of a fatal dengue myocarditis showing evidence for dengue virus-induced lesion. Eur Heart J Acute Cardiovasc Care 2:2 (2013), 127–130.
16. [16] Cohen, A.L., Dowell, S.F., Nisalak, A., Mammen, M.P. Jr., Petkanchanapong, W., Fisk, T.L., Rapid diagnostic tests for dengue and leptospirosis: antibody detection is insensitive at presentation. Trop Med Int Health 12:1 (2007), 47–51.
17. [17] Varma, M.D., Vengalil, S., Vallabhajosyula, S., Krishnakumar, P.C., Vidyasagar, S., Leptospirosis and dengue fever: a predictive model for early differentiation based on clinical and biochemical parameters. Trop Doct 44:2 (2014), 100–102.
18. [18] Lindo, J., Brown, P.D., Vickers, I., Brown, M., Jackson, S.T., Lewis-Fuller, E., Leptospirosis and malaria as causes of febrile illness during a dengue epidemic in Jamaica. Pathog Glob Health 107:6 (2013), 329–334.
19. [19] Hiwat, H., Mitro, S., Samjhawan, A., Sardjoe, P., Soekhoe, T., Takken, W., Collapse of Anopheles darlingi populations in Suriname after introduction of insecticide-treated nets (ITNs); malaria down to near elimination level. Am J Trop Med Hyg 86:4 (2012), 649–655.
20. [20] Dejnirattisai, W., Supasa, P., Wongwiwat, W., Rouvinski, A., Barba-Spaeth, G., Duangchinda, T., et al. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nat Immunol, 23(June), 2016.
21. [21] Guilarde, A.O., Turchi, M.D., Siqueira, J.B. Jr., Feres, V.C., Rocha, B., Levi, J.E., et al. Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response. J Infect Dis 197:6 (2008), 817–824.
22. [22] Deeba, F., Islam, A., Kazim, S.N., Naqvi, I.H., Broor, S., Ahmed, A., et al. Chikungunya virus: recent advances in epidemiology, host pathogen interaction and vaccine strategies. Pathog Dis, 74(Dcember (3)), 2016 Epub.
23. [23] Makhluf, H., Shresta, S., Innate antiviral immunity against dengue virus. Crit Rev Immunol 35:3 (2015), 253–260.
24. [24] Tappe, D., Pérez-Girón, J.V., Zammarchi, L., Rissland, J., Ferreira, D.F., Jaenisch, T., et al. Cytokine kinetics of Zika virus-infected patients from acute to reconvalescent phase. Med Microbiol Immunol 205:3 (2016), 269–273.
25. [25] Beatty, R.P., Puerta-Guardo, H., Killingbeck, S., Glasner, D., Harris, E., Dengue virus non-structural protein 1 triggers endothelial permeability and vascular leak that can be inhibited by anti-NS1 antibodies. Sci Transl Med, 7(304), 2015 304ra141.